Complete Blood Count-derived Indexes in Inflammatory Modic Changes
Launched by VEYSEL DELEN, MD · May 28, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
Patients and Methods: A total of 48 patients with MCs (type I/type II=24/24) were included in this study. Their demographic, clinical and hematologic characteristics were recorded. A 10 cm Visual Analog Scale (VAS) was used to detect low back pain intensity. Systemic inflammatory biomarkers including NLR, monocyte/lymphocyte (MLR), platelet/lymphocyte (PLR), neutrophil/lymphocyte\*platelet (NLPR), systemic inflammatory index (SII), systemic inflammatory response index (SIRI), and aggregate index of systemic inflammation (AISI) were derived from whole blood cell count.
Keywords: Neutrophil-...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Inclusion criteria were male or female with type I or type II MCs, aged ≥18 and ≤64 years old, and accepted informed consent to participation.
- Exclusion Criteria:
- • type III MCs and a combination of MCs' types were excluded. In addition, acute low back pain, spinal deformities, inflammatory diseases, cancers, heart diseases, stroke, lactation, pregnancy, psychiatric disorders, and extreme obesity (BMI≥40 kg/m²) were also excluded.
About Veysel Delen, Md
Veysel Delen, MD, is a dedicated clinical trial sponsor with a robust background in medical research and patient care. With a commitment to advancing healthcare through innovative clinical studies, Dr. Delen leads a team focused on developing and evaluating new therapeutic interventions. His expertise spans various medical disciplines, ensuring a comprehensive approach to trial design and execution. Dr. Delen is passionate about improving patient outcomes and contributing to the scientific community, making him a reliable partner in the pursuit of medical advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
şanlıurfa, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0